The FDA don’t deal with gross incompetent liars and class their products as breakthrough devices
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to announce that the FDA has granted RadioGel Precision Radionuclide Therapy the designation as a Breakthrough Device pursuant to the FDA’s Breakthrough Devices Program.$RDGL